• info@dee-p.org

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Inchstone Results &  Publications

Results

Publications

DEE Parents Speak Survey

Between Summer and Fall of 2023, we launched the DEE Parents Speak survey. We had 267 caregivers generously give their time to complete this extensive 2-part survey. Keep scrolling to see an overview of the survey results!

Overview

Caregivers of children with severe to profound impairments responded to our DEE Parents Speak survey. These responses are directly helping us develop measures to capture clinical trial outcomes.  This page contains an overview of the project so far, general results, and a breakdown by disease groups. If you have specific questions or want to get involved in research, email us at inchstones@deepconnections.net

%

Sex (proportion female)

%

Autism Diagnosis

%

Epilepsy Diagnosis

%

Unique Disease Groups

Good Days

Bad Days

Disease Specific Dashboards

Click each image to learn more.

Inchstone Research Publications

We prioritize publishing our research and results to make them as widely accessible as possible. If you have any trouble downloading an article, or if you have any questions, please reach out to us at kelly@d-de.org.

Patient-Advocate-Led Global Coalition Adapting Fit-For-Purpose Outcomes Measures to Assure Meaningful Inclusion of DEEs in Clinical Trials

Caregiver-Reported Quality of Life in Individuals with Developmental and Epileptic Encephalopathy and Other Severe Neurodevelopmental Encephalopathies

Clinical Utility of the Developmental Profile-4 in Individuals with Developmental and Epileptic Encephalopathies and Severe to Profound Functional Impairment

FDA Patient-Focused Drug Development Guidances: Considerations for Trial Readiness in Rare Developmental and Epileptic Encephalopathies

Novel Approaches to Measuring Cognition in Individuals with Severe to Profound Functional Impairment: A Pilot Study in SCN2A-Related Disorders

The Feasibility of Personalized Endpoints in Assessing Treatment Outcomes for Rare Diseases: A Pilot Study of Goal Attainment Scaling in SCN2A-Associated Developmental Epileptic Encephalopathy

Caregiver-Reported Meaningful Change in Functional Domains for Individuals with Developmental and Epileptic Encephalopathy: A Convergent Mixed-methods Design

Impact of Non-Seizure Outcome Domains and Caregiver Priorities for Young People with Developmental and Epileptic Encephalopathies: A Community Survey

What Does Better Look Like in Individuals with Severe Neurodevelopmental Impairments? A Qualitative Descriptive Sstudy on SCN2A-Related Developmental and Epileptic Encephalopathy